PressJanuary 7, 2022 Field Trip Announces Intention to Make Applications on Behalf of Patients to Health Canada’s Special Access Program (SAP) for Access to Psilocybin and MDMA-Assisted Therapies
PressJanuary 5, 2022 Red Light Holland Expands iMicrodose Branded Product Offerings and Launches the Sale of All-in-One Mushroom Fruiting Extracts; Capsules and Tinctures
PressJanuary 3, 2022 Awakn Life Sciences Reports Fiscal Third Quarter 2021 Financial Results and Business Highlights
PressDecember 29, 2021 Mindset Pharma Announces Filing of International Patent Application Covering its Family 3 “Microdose” Compounds
PressDecember 28, 2021 Revive Therapeutics Expands Bucillamine Research to Treat Omicron Variant and Adds Inflammatory Markers to FDA Phase 3 Clinical Trial
PressDecember 27, 2021 Tryp Therapeutics Announces Advancement of Phase 2a Clinical Trial in Binge Eating Disorder
PressDecember 22, 2021 Tryp Therapeutics Announces Fiscal Year 2021 Financial Results and Reports on Corporate Highlights
PressDecember 21, 2021 Optimi Health Receives Dealers License Inspection and Introduces Quality Assurance Department
PressDecember 20, 2021 HAVN Life Enters into Definitive Agreement to Acquire Spore Life Sciences Inc.
PressDecember 20, 2021 PharmaTher Enters Into Process Development Agreement With LTS LOHMANN for Ketamine Microneedle Patch
PressDecember 17, 2021 MYND Life Sciences Acquires Rights for the Use of Psychedelics to Treat Alzheimer’s Disease and other Dementias
PressDecember 16, 2021 Entheon Biomedical Announces EEG Patent Application & Provides Research Update
PressDecember 15, 2021 Apeiron and Other Key Shareholders of atai Life Sciences Reinforce Support by Entering into Extended, Voluntary Share Lock-up Agreements
PressDecember 14, 2021 Atai Life Sciences Has Been Selected for Addition to the NASDAQ Biotechnology Index
